Physician profile
Matthew Steadmon
NPI 1104137793
$1,959.63
in general payments reported to CMS, 2019-2025
18 companies · $552 in 2025
The $552 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $157 · 2021: $137 · 2022: $245 · 2023: $301 · 2024: $407 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,260.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $456.69 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $368.94 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $302.63 | 2021-2025 | Dupixent, Libtayo |
| Abbvie INC. | $251.92 | 2019-2025 | Skyrizi, Botox |
| Janssen Scientific Affairs, LLC | $112.61 | 2022 | |
| Genentech USA, INC. | $93.14 | 2019-2024 | Erivedge |
| Organon LLC | $71.84 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $63.81 | 2022-2024 | Sotyktu |
| Leo Pharma INC. | $52.49 | 2023-2025 | Adbry |
| Pfizer INC. | $42.40 | 2019-2023 | |
| Dermavant Sciences, INC. | $25.45 | 2024 | Vtama |
| Galderma Laboratories, L.P. | $24.91 | 2024 | Oracea |
| Convatec INC. | $22.75 | 2023 | |
| Almirall LLC | $16.25 | 2022 | |
| Lilly USA, LLC | $16.15 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $14.83 | 2022 | |
| Janssen Biotech, INC. | $11.78 | 2020 | |
| Acell, INC. | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Steadmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.